Search

ICADE.

Closed

SectorHealthcare

21.16 -0.84

Overview

Share price change

24h

Current

Min

21.08

Max

21.34

Key metrics

By Trading Economics

Income

-92M

Sales

-126M

624M

Dividend yield

20.05

Profit margin

-14.707

Employees

969

EBITDA

-95M

138M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

-14.41% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

20.05%

2.26%

Next Earnings

17 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-2.5M

1.6B

Previous open

22

Previous close

21.16

News Sentiment

By Acuity

50%

50%

173 / 370 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

ICADE. Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jan 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12 Jan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Jan 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12 Jan 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 Jan 2026, 23:18 UTC

Acquisitions, Mergers, Takeovers

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 Jan 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Jan 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 Jan 2026, 21:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

12 Jan 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Jan 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 Jan 2026, 20:54 UTC

Earnings

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 Jan 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 Jan 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 Jan 2026, 20:18 UTC

Acquisitions, Mergers, Takeovers

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 Jan 2026, 20:18 UTC

Acquisitions, Mergers, Takeovers

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 Jan 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 Jan 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 Jan 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Jan 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 Jan 2026, 19:24 UTC

Acquisitions, Mergers, Takeovers

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 Jan 2026, 19:22 UTC

Acquisitions, Mergers, Takeovers

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 Jan 2026, 18:21 UTC

Acquisitions, Mergers, Takeovers

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 Jan 2026, 18:20 UTC

Acquisitions, Mergers, Takeovers

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 Jan 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 Jan 2026, 18:16 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 Jan 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Jan 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 Jan 2026, 18:01 UTC

Acquisitions, Mergers, Takeovers

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 Jan 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

ICADE. Forecast

Price Target

By TipRanks

-14.41% downside

12 Months Forecast

Average 18.3 EUR  -14.41%

High 21 EUR

Low 15.9 EUR

Based on 4 Wall Street analysts offering 12 month price targets forICADE. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

4 ratings

0

Buy

1

Hold

3

Sell

Technical Score

By Trading Central

21.04 / 21.4Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

173 / 370 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.
help-icon Live chat